The independent global IoT specialist, KORE, has created an ongoing partnership with Dexcom Inc., a provider of continuous glucose monitoring (CGM). This will rapidly deliver an innovative remote patient monitoring solution to assist care providers during the COVID-19 global pandemic.
Using the Dexcom G6 CGM system, healthcare professionals can reduce both the use of personal protective equipment (PPE) and the number of in-person glucose level checks on patients who are receiving care for COVID-19 in the hospital.
In order to successfully monitor the glucose levels of patients who are being treated for COVID-19, healthcare professionals (HCPs) must equip themselves with fresh personal protective equipment (PPE) for each visit. Patients on insulin need several glucose checks per day, up to one per hour – meaning multiple PPEs are discarded each day, for each patient. With many hospitals and healthcare workers already experiencing a shortage or lack of proper PPE, the risk of exposure and infection grows significantly – as do the costs.
Dexcom’s solution allows for continuous glucose monitoring by measuring glucose levels automatically every five minutes and transmitting the data to a handheld mobile device, which can be accessed from a safe distance. HCPs can then safely and accurately monitor blood glucose levels remotely – only using one set of PPE daily in order to change out the device, or other times immediate intervention is necessary.
“Doing all that we can to support the health and safety of the patients and healthcare workers currently battling this novel virus is a top priority for our company,” says Matt Dolan, senior vice president and general manager at Dexcom. “It’s our hope to reduce their exposure, eliminate unnecessary waste of limited PPE supplies, and improve the efficiency of the hospitals who are treating these patients.”
Dexcom approached KORE Health to help launch this solution with record speed in order to maximise protection for areas that need it most. In reference to the project, Bryan Lubel, EVP of IoT managed services, comments, “KORE Health was able to procure fully certified and ISO-compliant devices, complete engineering testing and approval, identify connectivity solutions and deploy the first wave of equipped devices in just over a week – ensuring rapid speed-to-market for this critical solution.”
“We are in an unprecedented situation and the KORE team is looking for ways to help,” commented Romil Bahl, president & CEO at KORE. “When the Dexcom team approached us to help in short timeframes, our healthcare team was up to the challenge.”
“We are honoured that our knowledge and experience in connectivity and device procurement, certification, and deployment is playing a role in this innovative solution and that we are able to help in the global war against COVID-19. Our greatest thanks to both Dexcom and our front-line warriors as they take on this invisible enemy,” Bahl adds.
“We are grateful to the team at KORE for meeting our requirements in such a short time in order to quickly launch this solution,” says Dolan. “Together, we will continue to do whatever we can to help those on the front lines fight this novel coronavirus.”